Eucomed's Profile 2003 industry data now available:
This article was originally published in Clinica
Executive Summary
Europe's largest medical device industry association, Eucomed, has now finalised its Industry Profile 2003 and invited orders for the 75-page illustrated book. This Profile will be in much demand since, as the European Commission openly admits, there is a dearth of accurate data in this area. The report, which will officially be released at Eucomed's AGM in Cannes next week, is split into six main chapters. These are as follows: what is the medical technology industry; the medical technology market place (including expenditure on technology, market figures and import and export figures); healthcare priorities (including human tissues, diabetes and cancer); medical technology and EU legislation; international initiatives; and challenges and opportunities ahead.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.